Angelalign Technology (HKSE:06699) FCF Margin % : 23.23% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Angelalign Technology FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Angelalign Technology's Free Cash Flow for the six months ended in Dec. 2023 was HK$218 Mil. Angelalign Technology's Revenue for the six months ended in Dec. 2023 was HK$940 Mil. Therefore, Angelalign Technology's FCF Margin % for the quarter that ended in Dec. 2023 was 23.23%.

As of today, Angelalign Technology's current FCF Yield % is 0.50%.

The historical rank and industry rank for Angelalign Technology's FCF Margin % or its related term are showing as below:

HKSE:06699' s FCF Margin % Range Over the Past 10 Years
Min: 3.47 Med: 19.71 Max: 46.85
Current: 3.47

During the past 6 years, the highest FCF Margin % of Angelalign Technology was 46.85%. The lowest was 3.47%. And the median was 19.71%.

HKSE:06699's FCF Margin % is ranked better than
67.43% of 832 companies
in the Medical Devices & Instruments industry
Industry Median: -7.38 vs HKSE:06699: 3.47

Angelalign Technology FCF Margin % Historical Data

The historical data trend for Angelalign Technology's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Angelalign Technology FCF Margin % Chart

Angelalign Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

46.85

44.90

19.03

4.05

3.47

Angelalign Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial					21.41	-0.78	8.01	-24.08	23.23

Competitive Comparison of Angelalign Technology's FCF Margin %

For the Medical Instruments & Supplies subindustry, Angelalign Technology's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Angelalign Technology's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Angelalign Technology's FCF Margin % falls into.

Angelalign Technology FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Angelalign Technology's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	56.094	/	1614.377
	=	3.47 %

Angelalign Technology's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	218.396	/	940.25
	=	23.23 %

Angelalign Technology FCF Margin % Related Terms

Thank you for viewing the detailed overview of Angelalign Technology's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Angelalign Technology (HKSE:06699) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Angelalign Technology Inc (HKSE:06699) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

AGLFF:USA

Address

No. 500 Zhengli Road, 6th Floor - 7th Floor, Building No. 7, KIC Business Center, Yangpu District, Shanghai, CHN

Website

https://www.angelalign.com

Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontics solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review and modify treatment plans.

Executives

Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Morgan Stanley	2201 Interest of corporation controlled by you
Carecapital Ea, Inc	2201 Interest of corporation controlled by you
Carecapital Management Group Llc	2201 Interest of corporation controlled by you
Carecapital Moonstone Holdings Limited	2201 Interest of corporation controlled by you
Carecapital Dental Holdings Limited	2201 Interest of corporation controlled by you
Feng Dai	2201 Interest of corporation controlled by you
Shore Lead Limited	2201 Interest of corporation controlled by you
Sky Honour Enterprises Limited	2101 Beneficial owner
Li Huamin	2307 Founder of a discretionary trust who can infl
Carecapital Orthotech Limited	2101 Beneficial owner
Chen Kai	2201 Interest of corporation controlled by you
Jovial Day Global Limited	2201 Interest of corporation controlled by you
Vast Luck Global Limited	2101 Beneficial owner
Xing Zheng Quan Qiu Ji Jin Guan Li You Xian Gong Si	2102 Investment manager

Angelalign Technology (HKSE:06699) Headlines

No Headlines